Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Details for Australian Patent Application No. 2009202900 (hide)

International Classifications

Event Publications

30 July 2009 Complete Application Filed

6 August 2009 Application Open to Public Inspection

Published as AU-B-2009202900

11 February 2010 Application Accepted

Published as AU-B-2009202900

3 June 2010 Corrigenda

Applications Accepted - Name Index Under the Name Arena Pharmaceuticals, Inc., Application No. 2009202900, under INID (72) correct the inventor to read Al-Shamma, Hussein A. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2004216002 The Trustees of the University of Pennsylvania 2004297504 W.R. Grace & Co.-Conn. 2005205373 Cyrium Technologies Incorporated 2005254927 A

10 June 2010 Standard Patent Sealed

19 August 2010 Amendment Made

The nature of the amendment is: Amend the name of the co-inventor from Al-Shamma, Hussein A. to Al-Shamma, Hussien A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.